FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

39537011000036102: intraocular injection dose form (AU qualifier)


Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
170641011000036119 intraocular injection en Synonym Active Case sensitive Australian Medicines Terminology module
170642011000036113 intraocular injection dose form (AU qualifier) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
intraocular injection Is a injection true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
ocriplasmin 375 microgram/0.3 mL intraocular injection, vial has manufactured dose form True intraocular injection Inferred relationship Some
Jetrea RTU 375 microgram/0.3 mL intraocular injection, 0.3 mL vial has manufactured dose form True intraocular injection Inferred relationship Some
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe has manufactured dose form False intraocular injection Inferred relationship Some
Viscoat intraocular injection, 0.5 mL syringe has manufactured dose form False intraocular injection Inferred relationship Some
brolucizumab 6 mg/0.05 mL intraocular injection, syringe has manufactured dose form True intraocular injection Inferred relationship Some
brolucizumab 6 mg/0.05 mL intraocular injection, vial has manufactured dose form True intraocular injection Inferred relationship Some
Beovu 6 mg/0.05 mL intraocular injection, 0.05 mL syringe has manufactured dose form True intraocular injection Inferred relationship Some
Beovu 6 mg/0.05 mL intraocular injection, 0.05 mL vial has manufactured dose form True intraocular injection Inferred relationship Some
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe has manufactured dose form True intraocular injection Inferred relationship Some
Viscoat intraocular injection, 0.5 mL syringe has manufactured dose form True intraocular injection Inferred relationship Some
Vsiqq 6 mg/0.05 mL intraocular injection, 0.05 mL vial has manufactured dose form True intraocular injection Inferred relationship Some
Vabysmo 6 mg/0.05 mL intraocular injection, 0.24 mL vial has manufactured dose form False intraocular injection Inferred relationship Some
faricimab 6 mg/0.05 mL intraocular injection, 0.24 mL vial has manufactured dose form False intraocular injection Inferred relationship Some
faricimab 6 mg/0.05 mL intraocular injection, vial has manufactured dose form True intraocular injection Inferred relationship Some
Vabysmo 6 mg/0.05 mL intraocular injection, 0.05 mL vial has manufactured dose form True intraocular injection Inferred relationship Some
carbachol 0.01% (150 microgram/1.5 mL) intraocular injection, vial has manufactured dose form True intraocular injection Inferred relationship Some
Miostat 0.01% (150 microgram/1.5 mL) intraocular injection, 1.5 mL vial has manufactured dose form True intraocular injection Inferred relationship Some

This concept is not in any reference sets

Back to Start